Quintiles Transnational Holdings Inc. (Q)
-NYSE 44.01 
0.12(0.27%) 1:23PM EDT - Nasdaq Real Time Price
| Prev Close: | 43.89 |
|---|
| Open: | 43.66 |
|---|
| Bid: | 43.99 x 500 |
|---|
| Ask: | 44.00 x 200 |
|---|
| 1y Target Est: | 47.09 |
|---|
| Beta: | 0.71 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 43.01 - 44.09 |
|---|
| 52wk Range: | 41.78 - 46.50 |
|---|
| Volume: | 158,978 |
|---|
| Avg Vol (3m): | 1,465,180 |
|---|
| Market Cap: | 5.10B |
|---|
| P/E (ttm): | 28.37 |
|---|
| EPS (ttm): | 1.55 |
|---|
| Div & Yield: | 0.32 (4.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Quintiles initiated with a Neutral at Citigrouptheflyonthewall.com(Wed 6:33AM EDT)
- New Analyst Coverage: LNKD, Q, TMUSat Forbes(Tue, Jun 18)
- Analysts' Actions: CRL CVLT LNKD Q WETFTheStreet(Tue, Jun 18)
- Quintiles Named a “Best Place to Work in IT” by Computerworld for Fifth TimeBusiness Wire(Tue, Jun 18)
- U.S. Stock Futures Are Little Changed Before Housing Dataat Bloomberg(Tue, Jun 18)
- Quintiles initiated with an Outperform at Wells Fargotheflyonthewall.com(Tue, Jun 18)
- Quintiles initiated with an Overweight at Piper Jaffraytheflyonthewall.com(Tue, Jun 18)
- Coverage initiated on Quintiles Transnational by Robert W. BairdBriefing.com(Tue, Jun 18)
- David Cuthbert, President and CEO of Alteva, Inc. (ALTV), Interviews with The Wall Street TranscriptWall Street Transcript(Wed, Jun 12)
- Quintiles initiated with an Underperform at Sterne Ageetheflyonthewall.com(Wed, Jun 12)
- Quintiles Transnational re-initiated with a Neutral at Sterne Ageetheflyonthewall.com(Wed, Jun 12)
- Parexel Trying To Clear Three-Weeks-Tight Buy Pointat Investor's Business Daily(Tue, Jun 11)
- Quintiles Infosario® Wins Informatica Innovation Award for Enterprise Data IntegrationBusiness Wire(Fri, Jun 7)
- KKR, Warburg, Cinven eye bids for clinical trial firm PRA -sourcesat Reuters(Tue, Jun 4)
- Quintiles Receives Award from Patient-Centered Outcomes Research Institute to Compare the Effectiveness of Uterine Fibroid Treatments in Real-World PracticeBusiness Wire(Tue, Jun 4)
Key Statistics
| Forward P/E (1 yr): | 20.08 |
|---|
| P/S (ttm): | 1.36 |
|---|
| Ex-Dividend Date: | 16-Feb-11 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.90 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.47 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.99 |
|---|
Business Summary
Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe and Africa, and the Asia-Pacific.
View More